Gapping up
In reaction to strong earnings/guidance:
- CSBR +19.5%, SHLD +18.2%, RLGT +16.3%, ADBE +0.4%
Other news:
- STAA +10.4% (continued strength after announcing FDA approval of the PMA Supplement for the Visian Toric ICL)
- RLGY +5.2% (to replace Education Realty Trust (EDR) in the S&P MidCap 400)
- EXTR +2.2% (CFO to leave co; Co also reaffirms Q1 guidance, given Aug 8)
- CASI +2.1% (announces $48.5 mln private placement)
- LB +2% (to close all 23 Henri Bendel stores and the Henri Bendel e-commerce website in 2019)
- DOCU +1.3% (prices secondary offering of 8,060,550 shares of common stock at $55.00 per share, prices upsized offering of $500 mln principal amount of 0.50% Convertible Senior Notes due 2023)
- INXN +1.2% (increases its 2018 annual capital expenditure guidance range to EUR 425 million to EUR 450 million)
Analyst comments:
- ARGX +6.1% (initiated with Buy at Stifel)
- GLW +2% (upgraded to Buy from Neutral at Citigroup)
- PRSP +1.9% (upgraded to Outperform from Market Perform at Wells Fargo)
- WIX +1.6% (initiated with a Outperform at Wedbush)
- ESPR +1.4% (ticking higher; resumed with Buy at Stifel)
- YELP +1.2% (initiated with a Outperform at Wedbush)
- VNDA +1.1% (initiated with Buy at Stifel)
- ZGNX +1.1% (initiated with a Buy at BofA/Merrill)
- SHOP +1% (initiated with a Outperform at Wedbush)
- GRUB +1% (initiated with a Outperform at Wedbush ; tgt $180 and also added to Best Ideas List)
- PH +1% (upgraded to Buy from Neutral at Buckingham Research)
- VFC +0.9% (upgraded to Outperform from Market Perform at Cowen)
- SRPT +0.8% (resumed with a Buy at BofA/Merrill)
![]()